Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer Cells

Rayna Rosati(Wayne State University), Zhihui Qin(Harbin Medical University)
Molecular Pharmacology
July 6, 2016
Cited by 21


Related Papers

No related papers found

Powered by citation graph analysis